Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158)

Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone, Mario Scartozzi, Eufemia Stefania Lutrino, Davide Melisi, Lorenzo Antonuzzo, Antonio Pellegrino, Laura FerrariRoberto Bordonaro, Caterina Vivaldi, Lorenzo Gerratana, Silvia Bozzarelli, Roberto Filippi, Domenico Bilancia, Marco Russano, Giuseppe Aprile

Research output: Contribution to journalComment/debatepeer-review

Abstract

The Oncologist 2017;22:1463–1469; first published on August 31, 2017; http://dx.doi.org/10.1634/theoncologist.2017-0158 Francesco Leone's affiliation was incorrectly shown in the original publication of this article. This erratum corrects that error, and the online version of the article has been updated to show the correct affiliation: Medical Oncology, University of Turin, Candiolo Cancer Institute, FPO, IRCCS, Turin, Italy.

Original languageEnglish
Number of pages1
JournalOncologist
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158)'. Together they form a unique fingerprint.

Cite this